A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (clinicaltrials.gov) - Apr 11, 2023 - P2a | N=24 | Recruiting | Sponsor: Kezar Life Sciences, Inc. | Trial completion date: Sep 2024 ➔ Mar 2025 | Initiation date: Jan 2023 ➔ Apr 2023
Trial completion date • Trial initiation date • Hepatology • Immunology • Inflammation
|